Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Inhibitory Effect of a Drug Metabolizing Enzyme CYP3A4 on Spices

향신료의 약물대사효소 CYP3A4 저해효과

  • Cha, Bae-Cheon (Department of Bio-industry and technology, Sangji University)
  • 차배천 (상지대학교 생명자원과학대학 생명산업학과)
  • Published : 2003.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

For the determination of inhibiting cytochrome P450(CYP)3A4 activity, an improvement HPLC method was established by using a new internal standard and solvent system. Moreover, CYP3A4 amount for a optimum reaction of enzyme was determined by a comparative study with a variety concentration of enzyme. Using a established method, inhibitory effect of CYP3A4 that is drug metabolizing enzyme Investigated on EtOAc extracts of 5-class spices. As a result of experiment, EtOAc extract of white pepper (Piper nigrum L.) showed strong inhibitory activity. On a continuous experiment, the fraction 2, 4 and 5 of while pepper extract showed remarkable inhibitory activity. Pipeline, a main constituent of pepper was not included in these fraction. It is suggested that major compounds for the inhibitory activity of white pepper may be other ingredient that is not piperine.

Keywords

References

  1. Wrighton, S. A. and Stevens, J. C. (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev.Toxicol. 22: 1-21 https://doi.org/10.3109/10408449209145319
  2. Nelson, D. R., Koymans, L., Kamataki, T, Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsa1us, I. C. and Nebert, D. W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Phannacogenetics6: 1-42 https://doi.org/10.1097/00008571-199602000-00002
  3. Shimada, T, Yamazaki, H., Mimura, M., lnui, Y and Guengerich, F. P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Phannacol. Exp. Ther. 270: 414-423
  4. Rendic, S. and DiCarlo, F. J. (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab. Rev. 29: 413-580 https://doi.org/10.1103/PhysRev.29.413
  5. Williams, M. L., Lennard, M. S., Martin, I. J. and Tucker, G. T. (1994) lnterindividual variation in the isomerization of 4hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450. Carcinogenesis 15: 2733-2738 https://doi.org/10.1093/carcin/15.12.2733
  6. Granberg, A. L., Brunstrom, B. and Brandt, I. (2000) Cytochrome P450-dependent binding of 7,12-dimethylbenz[a]anthracene (DMBA) and benz. Arch. Toxicol. 74: 593-601 https://doi.org/10.1007/s002040000171
  7. Rushmore, T H. and Kong, A. N. (2002) Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 3: 481-490 https://doi.org/10.2174/1389200023337171
  8. Kumar, G. N. and Surapaneni, S. (2001) Role of drug metabolism in drug discovery and development. Med. Res. Rev. 21: 397-411 https://doi.org/10.1103/PhysRev.21.397
  9. Fukuda, K., Ohta, T., Oshima, Y, Ohashi, N., Yoshikawa, M. and Yamazoe, Y. (1997) Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 7: 391-396 https://doi.org/10.1097/00008571-199710000-00008
  10. Peter de, B., Diederik, F. S., Kehrer, J. V., and Alex, S. (2001)Liquid chromatographic determination of ketoconazole, a potent inhibitor of CYP3A4-mediated metabolism. J. Chromatogr. B 753: 395-400 https://doi.org/10.1016/S0378-4347(00)00573-9
  11. Yee, G. C., Stanley, D. L., Pessa, L. J., Dalla Costa, T, Beltz, S. E., Ruiz, J. and Lowenthal, D. T (1995) Effect of grapefruit juice on blood cyclosporin concentration. Lancet 345: 955-956 https://doi.org/10.1016/S0140-6736(95)90700-9
  12. Hukkinen, S. K., Varhe, A., Olkkola, K. T and Neuvonen, P. J. (1995) Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin. Phannacol. Ther. 58: 127-131 https://doi.org/10.1016/0009-9236(95)90188-4
  13. Dresser, G. K., Wacher, V., Wong, S., Wong, H. T. and Bailey, D. G. (2002) Evaluation of peppermint oil and ascorby1 palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin. Phannacol. Ther. 72: 247-255 https://doi.org/10.1067/mcp.2002.126409
  14. Tsunoda, S. M., Harris, R. Z., Christians, u, Velez, R. L., Freeman, R. B., Benet, L. Z. and Warshaw, A. (2001) Red wine decreases cyclosporine bioavailability. Clin. Pharmacol. Ther. 70: 462-467
  15. Muto, S., Fujita, K., Yamazaki, Y. and Kamataki, T. (2001) Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 479: 197-206 https://doi.org/10.1016/S0027-5107(01)00204-4
  16. Budzinski, J. W., Foster, B. C., Vandenhoek, S. and Amason, J. T. (2000) An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7: 273-282 https://doi.org/10.1016/S0944-7113(00)80044-6
  17. Obach, R. S. (2000) Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther. 294: 88-95
  18. Henderson, M. C, Miranda, C. L., Stevens, J. F., Deinzer, M. L. and Buhler, D. R. (2000) In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30: 235-251 https://doi.org/10.1080/004982500237631
  19. Parmar, V. S., Jain, S. C., Bisht, K. S., Jain, R., Taneja, P., Jha, A., Tyagi, O. D., Prasad, A. K., Wengel, J., Olsen, C. E. and Boll, P. M. (1997) Phytochemistry of the genus piper. Phytochemistry 46: 597-673 https://doi.org/10.1016/S0031-9422(97)00328-2
  20. Stohr, J. R., Xiao, P. G. and Bauer, R. (2001) Constituents of Chinese Piper species and their inhibitory activity on prostaglandin and leukotriene biosynthesis in vitro. J. Ethnopharmacol. 75: 133-139 https://doi.org/10.1016/S0378-8741(00)00397-4